X-22 IND clearance by FDA for 22nd Century’s Phase II-B Smoking Cessation Clinical Trial
22nd Century Group, Inc. (OTCBB: XXII) recently publicized that the US-FDA has cleared their X-22 (a prescription smoking cessation aid)
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine